Wednesday, October 13, 2021 @ 3pm CST via Zoom

Description:

This program focuses on building awareness among patients and caregivers about Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML), and how to foster an open dialogue with your health care team about treatment options, side effect management, and living with chronic blood cancers.

About Dr. Ehab Atallah:

Dr. Atallah's interest is in the treatment of patients with leukemia and other hematological malignancies. His main goal is individualized patient care because each patient has different issues, opinions and priorities. Dr. Atallah believes this can best be achieved by good communication and actively involving patients in their care.

Ehab Atallah, MD, is a Professor of Medicine and Section Head of hematological malignancies in the Medical College of Wisconsin Division of Hematology and Oncology, specializing in leukemia and myelodysplastic syndromes at Froedtert Hospital. He graduated from Cairo University School of Medicine in 1994, then completed an internal medicine residency in the Cleveland Clinic Health System and a fellowship in hematology/oncology at the Karmanos Cancer Center in Detroit, Michigan, where he also served as Chief Fellow. He then went on to complete a leukemia fellowship at M.D. Anderson Cancer Center in Houston, Texas. Dr. Atallah is board certified in Internal Medicine, Medical Oncology, and Hematology. He has authored numerous publications, including journal articles, meeting abstracts, and a book chapter. In 2007, he received the American Society of Clinical Oncology Foundation Merit Award. His current research interests are treatment of patients with chronic myelogenous leukemia, chronic lymphocytic leukemia, acute lymphocytic leukemia, acute myelogenous leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.

Zoom access is provided, in part, by our Technology Sponsor, the Wisconsin Cancer Collaborative.